1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Neurovascular Devices Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Neurovascular Devices Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Neurovascular Devices Market Regional Analysis
6.2 North America Neurovascular Devices Market Revenue 2017-2027 (US$ Million)
6.3 North America Neurovascular Devices Market Forecast Analysis
7. North America Neurovascular Devices Market Analysis – by Product
7.1 Neurothrombectomy Devices
- 7.1.1 Overview
- 7.1.2 Neurothrombectomy Devices: North America Neurovascular Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Aneurysm Coiling & Embolization Devices
- 7.2.1 Overview
- 7.2.2 Aneurysm Coiling & Embolization Devices: North America Neurovascular Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Cerebral Balloon Angioplasty & Stenting Systems and Support Devices
- 7.3.1 Overview
- 7.3.2 Cerebral Balloon Angioplasty & Stenting Systems and Support Devices: North America Neurovascular Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America Neurovascular Devices Market Analysis – by Application
8.1 Cerebral Aneurysms
- 8.1.1 Overview
- 8.1.2 Cerebral Aneurysms: North America Neurovascular Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Ischemic Strokes
- 8.2.1 Overview
- 8.2.2 Ischemic Strokes: North America Neurovascular Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Arteriovenous Malformation & Fistulas
- 8.3.1 Overview
- 8.3.2 Arteriovenous Malformation & Fistulas: North America Neurovascular Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Other Applications
- 8.4.1 Overview
- 8.4.2 Other Applications: North America Neurovascular Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America Neurovascular Devices Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Neurovascular Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Ambulatory Surgical Centers
- 9.2.1 Overview
- 9.2.2 Ambulatory Surgical Centers: North America Neurovascular Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Specialized Clinics
- 9.3.1 Overview
- 9.3.2 Specialized Clinics: North America Neurovascular Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. North America Neurovascular Devices Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Neurovascular Devices Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 North America Neurovascular Devices Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North America Neurovascular Devices Market Breakdown, by Product
- 10.2.1.1.2 US: North America Neurovascular Devices Market Breakdown, by Application
- 10.2.1.1.3 US: North America Neurovascular Devices Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North America Neurovascular Devices Market Breakdown, by Product
- 10.2.1.2.2 Canada: North America Neurovascular Devices Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Neurovascular Devices Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Neurovascular Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North America Neurovascular Devices Market Breakdown, by Product
- 10.2.1.3.2 Mexico : North America Neurovascular Devices Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Neurovascular Devices Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Medtronic plc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Johnson and Johnson, Inc (DePuy Synthes)
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Penumbra, Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Terumo Corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 MicroPort Scientific Corporation
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Integer Holdings Corporation
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Memry Corporation
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Phenox GmbH
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations